Ascendis Pharma Endocrinology Division A/S
1 products tracked · names used in filings: Ascendis Pharma Endocrinology Division A/S
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Skytrofa (previously Lonapegsomatropin Ascendis Pharma) lonapegsomatropin | Authorised | 2022-01-11 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.